CAVIPRES questionnaire as a meassurement of quality of life in patients with prostate cancer in Spain: Daily clinical practice aplication

被引：6

作者：

Gomez-Veiga, F. ^{[1
]}

Cozar, J. M. ^{[2
]}

Guenthner, S. ^{[3
]}

Puyol-Pallas, M. ^{[4
]}

Silmi-Moyano, A. ^{[5
]}

Rebollo, F. J. ^{[6
]}

机构：

[1] Complejo Hosp Univ A Coruna, Serv Urol, La Coruna, Spain

[2] Hosp Virgen Nieves, Serv Urol, Granada, Spain

[3] Hosp Clin Valencia, Serv Urol, Valencia, Spain

[4] Hosp St Joan de Deu, Serv Urol, Barcelona, Spain

[5] Hosp Clin San Carlos, Serv Urol, Madrid, Spain

[6] Abbott Labs SA, Dept Med, Granada, Spain

来源：

ACTAS UROLOGICAS ESPANOLAS | 2010年 / 34卷 / 08期

关键词：

Quality of life; Prostate cancer; CAVIPRES; Questionnaire; Description; MEN; CHEMOTHERAPY; MITOXANTRONE; PREDNISONE; TRIALS; INDEX;

D O I：

10.1016/j.acuro.2010.05.001

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Introduction: Prostate cancer (PC) states as the most frequent tumor in elderly patients. Although no direct involvement in death-related, PC entails an important lost in patient's quality of life. There are several questionnaires adapted to Spanish in order to measure the health-related quality of life (HRQoL) in PC patients. Objectives: To describe the content and feasibility of the Spanish CAVIPRES questionnaire both in its short version to the clinical daily practice and also in the extended version to be used in the investigational protocols. Materials and methods: A detailed review of the different quality of life-related aspects of PC patients gathered in the questionnaire and a cross-comparison with other adapted HRQoL available is been performed. Results: The HRQoL CAVIPRES questionnaire gathers information regarding social and partner support, psychological conditions of the patients, and also life expectancies against disease outcome together with classical symptomatic parameters as other available and adapted questionnaires. Conclusion: The CAVIPRES questionnaire in its short version is an adequate, feasible, valid, reliable and sensitive to change in the measurement of HRQoL in PC patients. The extended version is valid to be used in clinical research of PC patients. Both versions have been donated by Abbott to the Spanish Association of Urology (AEU) and are available at AEU web site (www.eau.es). (C) 2010 AEU. Published by Elsevier Espana, S.L. All rights reserved.

引用

页码：686 / 693

页数：8

共 21 条

[1] Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer [J].

Armstrong, Andrew J. ;

Garrett-Mayer, Elizabeth ;

de Wit, Ronald ;

Tannock, Ian ;

Eisenberger, Mario .

CLINICAL CANCER RESEARCH, 2010, 16 (01) :203-211

[2] Quality, interpretation and presentation of European Organisation for Research and Treatment of Cancer quality of life questionnaire core 30 data in randomised controlled trials [J].

Cocks, Kim ;

King, Madeleine T. ;

Velikova, Galina ;

Fayers, Peter M. ;

Brown, Julia M. .

EUROPEAN JOURNAL OF CANCER, 2008, 44 (13) :1793-1798

[3]

COLLOCA G, 2010, MED ONCOL IN PRESS

[4] Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy prostate instrument [J].

Esper, P ;

Mo, F ;

Chodak, G ;

Sinner, M ;

Cella, D ;

Pienta, KJ .

UROLOGY, 1997, 50 (06) :920-928

[5] Estimates of cancer incidence and mortality in Europe in 2008 [J].

Ferlay, J. ;

Parkin, D. M. ;

Steliarova-Foucher, E. .

EUROPEAN JOURNAL OF CANCER, 2010, 46 (04) :765-781

[6]

FERRANS CE, 2007, J NATL CANC I MONOGR, V37, P22, DOI DOI 10.1093/JNCIMONOGRAPHS/LGM008

[7]

FOSSA SD, 1989, EUR UROL, V16, P335

[8] Current Prostate Cancer Treatments: Effect on Quality of Life [J].

Gomella, Leonard G. ;

Johannes, James ;

Trabulsi, Edouard J. .

UROLOGY, 2009, 73 (5A) :28-35

[9]

GOMEZ F, 2009, ACTAS UROL ESP, V33, P623

[10]

Granado de la Orden S, 2006, ACTAS UROL ESP, V30, P574, DOI [DOI 10.1016/S0210-4806(06)73497-0, 10.1016/s0210-4806(06)73497-0]

← 1 2 3 →